Literature DB >> 9852038

The death effector domain of PEA-15 is involved in its regulation of integrin activation.

J W Ramos1, T K Kojima, P E Hughes, C A Fenczik, M H Ginsberg.   

Abstract

Increased integrin ligand binding affinity (activation) is triggered by intracellular signaling events. A Ras-initiated mitogen-activated protein kinase pathway suppresses integrin activation in fibroblasts. We used expression cloning to isolate cDNAs that prevent Ras suppression of integrin activation. Here, we report that PEA-15, a small death effector domain (DED)-containing protein, blocks Ras suppression. PEA-15 does not block the capacity of Ras to activate the ERK mitogen-activated protein kinase pathway. Instead, it inhibits suppression via a pathway blocked by a dominant-negative form of the distinct small GTPase, R-Ras. Heretofore, all known DEDs functioned in the regulation of apoptosis. In contrast, the DED of PEA-15 is essential for its capacity to reverse suppression of integrin activation. Thus, certain DED-containing proteins can regulate integrin activation as opposed to apoptotic protease cascades.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9852038     DOI: 10.1074/jbc.273.51.33897

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  An Eph receptor regulates integrin activity through R-Ras.

Authors:  J X Zou; B Wang; M S Kalo; A H Zisch; E B Pasquale; E Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  Death effector domain protein PEA-15 potentiates Ras activation of extracellular signal receptor-activated kinase by an adhesion-independent mechanism.

Authors:  J W Ramos; P E Hughes; M W Renshaw; M A Schwartz; E Formstecher; H Chneiweiss; M H Ginsberg
Journal:  Mol Biol Cell       Date:  2000-09       Impact factor: 4.138

3.  The small GTP-binding protein R-Ras can influence integrin activation by antagonizing a Ras/Raf-initiated integrin suppression pathway.

Authors:  T Sethi; M H Ginsberg; J Downward; P E Hughes
Journal:  Mol Biol Cell       Date:  1999-06       Impact factor: 4.138

4.  RACK1 regulates integrin-mediated adhesion, protrusion, and chemotactic cell migration via its Src-binding site.

Authors:  Elisabeth A Cox; David Bennin; Ashley T Doan; Timothy O'Toole; Anna Huttenlocher
Journal:  Mol Biol Cell       Date:  2003-02       Impact factor: 4.138

5.  Suppression of integrin activation by activated Ras or Raf does not correlate with bulk activation of ERK MAP kinase.

Authors:  Paul E Hughes; Beat Oertli; Malene Hansen; Fan-Li Chou; Berthe M Willumsen; Mark H Ginsberg
Journal:  Mol Biol Cell       Date:  2002-07       Impact factor: 4.138

6.  Suppression of integrin activation by the membrane-distal sequence of the integrin alphaIIb cytoplasmic tail.

Authors:  Jun Yamanouchi; Takaaki Hato; Tatsushiro Tamura; Shigeru Fujita
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

Review 7.  Control of MAP kinase signaling to the nucleus.

Authors:  Kunio Kondoh; Satoru Torii; Eisuke Nishida
Journal:  Chromosoma       Date:  2005-05-18       Impact factor: 4.316

8.  Akt down-regulates ERK1/2 nuclear localization and angiotensin II-induced cell proliferation through PEA-15.

Authors:  Marianne Gervais; Céline Dugourd; Laurent Muller; Corinne Ardidie; Brigitte Canton; Laetitia Loviconi; Pierre Corvol; Hervé Chneiweiss; Catherine Monnot
Journal:  Mol Biol Cell       Date:  2006-07-05       Impact factor: 4.138

9.  An experimentally derived database of candidate Ras-interacting proteins.

Authors:  Lawrence E Goldfinger; Celeste Ptak; Erin D Jeffery; Jeffrey Shabanowitz; Jaewon Han; Jacob R Haling; Nicholas E Sherman; Jay W Fox; Donald F Hunt; Mark H Ginsberg
Journal:  J Proteome Res       Date:  2007-04-17       Impact factor: 4.466

10.  A phospholipase Cγ1-activated pathway regulates transcription in human vascular smooth muscle cells.

Authors:  Irene Hunter; Keith S Mascall; Joe W Ramos; Graeme F Nixon
Journal:  Cardiovasc Res       Date:  2011-02-01       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.